Results 261 to 270 of about 702,734 (359)

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan, María A. Piedrabuena, María A. Zarate, Sofía Rodríguez Murúa, Ezequiel I. Surace, Mauricio F. Farez, Marcela P. Fiol, María C. Ysrraelit, Jorge Correale   +8 more
wiley   +1 more source

Optimising access to vocational rehabilitation through multiple sclerosis charities: Protocol for a feasibility randomised controlled trial. [PDF]

PLoS One
De Dios Pérez B, Kendrick D, das Nair R, Evangelou N, Newsome I, Radford K.   +5 more
europepmc   +1 more source

Preventing injuries in children: cluster randomised controlled trial in primary care [PDF]

, 1999

openalex   +1 more source

Randomised controlled trials: sampling. [PDF]

British Journal of Clinical Pharmacology, 1982
openaire   +3 more sources

Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti‐GFAP Antibodies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction The kappa‐free light chain (κ‐FLC) index is known to be highly sensitive and specific for diagnosing multiple sclerosis (MS), while little is understood about lambda (λ)‐FLC. This study assessed the κ‐FLC and λ‐FLC indices in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.
Michael Levraut, Romain Marignier, Mikael Cohen, Jeanne Benoit, Cassandre Landes‐Chateau, Elisabeth Maillart, Marion Cremoni, Barbara Seitz‐Polski, Anne‐Laurie Pinto, Pauline Dumez, Jérôme Honnorat, Christine Lebrun‐Frenay   +11 more
wiley   +1 more source

Handheld fans for dyspnoea in respiratory failure: randomised controlled trial. [PDF]

BMJ Support Palliat Care
Yue D, Xie X, Chen G, Luo Z, Fan L, Sun D.   +5 more
europepmc   +1 more source

Human albumin administration in critically ill patients: systematic review of randomised controlled trials Why albumin may not work [PDF]

, 1998

openalex   +1 more source

High‐Efficacy Treatment in Neuromyelitis Optica Specturm Disorder Patients With Seropositive AQP4 Antibodies—A Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the effectiveness of high‐efficacy treatments (HET) and low‐efficacy treatments (LET) in NMOSD patients with anti‐aquaporin‐4 antibodies (AQP4‐ab). Methods In this multi‐center study, we analyzed 183 AQP4‐ab seropositive NMOSD patients who received immunosuppressive treatments (IST).
Xiang Li, Binbin Xue, Jia Li, Dewei Xie, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Xu Zhang, Junhui Xia, Jie Lin   +10 more
wiley   +1 more source

Development and Testing of an Out-of-School Hours Care Professional Development Program: A Pilot Cluster Randomised Controlled Trial. [PDF]

Health Promot J Austr
Woods AJ, Probst YC, Norman J, Wardle K, Ryan ST, Patel L, Crowe RK, Hammersley M, Morton K, Stanley RM, Taylor L, Okely AD.   +11 more
europepmc   +1 more source

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up [PDF]

, 1999
Nicholas J. Talley, J. Janssens, K. Lauritsen, I Rácz, E. Bolling‐Sternevald   +4 more
openalex   +1 more source